Health Care & Life Sciences » Biotechnology | GreenCross Labcell Corp.

GreenCross Labcell Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2014
2015
2016
2017
Sales/Revenue
30,901
34,489
42,419
45,796
Cost of Goods Sold (COGS) incl. D&A
25,158
27,477
32,461
35,837
Gross Income
5,743
7,012
9,958
9,960
SG&A Expense
3,007
3,712
7,781
8,178
EBIT
2,676
3,220
2,046
1,662
Unusual Expense
-
-
505
769
Non Operating Income/Expense
18
12
9
77
Pretax Income
2,726
3,274
1,904
1,542
Income Tax
1,060
1,014
424
485
Consolidated Net Income
1,667
2,260
2,328
1,057
Net Income
1,667
2,260
2,328
1,057
Net Income After Extraordinaries
1,667
2,260
2,328
1,057
Net Income Available to Common
1,667
2,260
2,328
1,057
EPS (Basic)
167.00
215.00
243.00
100.00
Basic Shares Outstanding
10
11
10
11
EPS (Diluted)
166.67
215.26
243.02
100.18
Diluted Shares Outstanding
10
11
10
11
EBITDA
3,135
3,751
2,653
2,368
Other Operating Expense
59
81
131
119
Non-Operating Interest Income
68
66
372
726

About GreenCross Labcell

View Profile
Address
4th Floor, Mokam Building
Yongin GY 16924
Korea, Republic Of
Employees -
Website http://www.gclabcell.com
Updated 09/14/2018
Green Cross Lab Cell Corp. engages in the provision of cord blood stem cell banking service. It operates through the following Businesses: Cell Therapy Products, Sample Test, Blood Banking, and Bio Logistics. The company was founded on June 21, 2011 and is headquartered in Yongin, South Korea.